Screener
10x Genomics, Inc. TXG Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
FAQ
- What is 10x Genomics, Inc.'s net income?
- 10x Genomics, Inc. (TXG) reported net income of -$17.93M in Q2 2026.
- How has 10x Genomics, Inc.'s net income changed year-over-year?
- 10x Genomics, Inc.'s net income decreased by 151.9% year-over-year, from $34.54M to -$17.93M.
- What is the long-term trend for 10x Genomics, Inc.'s net income?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s net income has grown at a -7.0% compound annual growth rate (CAGR), from -$58.22M to -$43.54M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about 10x Genomics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude